Shares trade higher but focus remains on Middle East conflict

Investors remained risk-averse on prospects of escalation in Israel's attack on Gaza in the wake of the Hamas attacks

Frankfurt-listed shares of BioNTech fell by more than 7% after partner Pfizer slashed its full-year revenue forecast on lower sales of its covid vaccine and treatment. File picture: Thomas Lohnes/Getty

European shares kicked off the week on a higher note, but investors remained risk-averse on prospects of escalation in the Middle East conflict.

The Stoxx 600 index of leading companies closed slightly higher with miners and retail stocks leading gains.